37.09
-0.585(-1.55%)
Currency In USD
| Previous Close | 37.67 |
| Open | 37.65 |
| Day High | 37.66 |
| Day Low | 37.09 |
| 52-Week High | 46.48 |
| 52-Week Low | 16.65 |
| Volume | 927,404 |
| Average Volume | 2.2M |
| Market Cap | 5.89B |
| PE | 148.34 |
| EPS | 0.25 |
| Moving Average 50 Days | 36.59 |
| Moving Average 200 Days | 32.98 |
| Change | -0.59 |
If you invested $1000 in TG Therapeutics, Inc. (TGTX) 10 years ago, it would be worth $2,006.76 as of July 12, 2025 at a share price of $37.085. Whereas If you bought $1000 worth of TG Therapeutics, Inc. (TGTX) shares 5 years ago, it would be worth $1,702.71 as of July 12, 2025 at a share price of $37.085.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
Jun 06, 2025 11:30 AM GMT
Fireside chat scheduled for Tuesday, June 10, 2025, at 10:40am ET.NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will parti
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire Inc.
Jun 02, 2025 12:00 PM GMT
Fireside chat scheduled for Wednesday, June 4, 2025, at 12:50pm ETNEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will parti
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire Inc.
May 30, 2025 11:30 AM GMT
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium